Status
Conditions
Treatments
About
Attention facilitates the allocation of processing resources and the control of behavior among competing stimuli. Current research focuses primarily on attention control networks in the dorsal frontoparietal (DAN) and ventral (VAN) cortex. However, typical laboratory experiments emphasize task-specific processing, neglecting the possible role of memory. Although a few studies have examined the contribution of memory to attention control, they have generally used simple tasks in the laboratory. These tasks are unlikely to produce true traces of episodic memory, which are - by definition - characterized by complex contextual information (what, where, when) and personal relevance. This research will therefore use an innovative protocol based on mobile phone technology to generate episodes in the participants' real lives and then measure the impact of these past personal experiences on attention allocation (by assessing eye movements) and on the activity of the DAN/VAN system (using functional imaging).
The main hypothesis of the study is that knowledge acquired during everyday life contributes to the subsequent allocation of processing resources, via engagement of the DAN/VAN attention systems.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
History of known neurological or psychiatric illness
Cognitive problems limiting the understanding of instructions
Recent taking psychotropic drugs (antidepressants, anxiolytics, antipsychotics). The main treatments not authorized during this research are the following: Psychotropic treatments (drugs that can induce changes in perception, sensation, mood, consciousness or behavior). Like what:
Antipsychotics (valproic acid, amisulpride, aripiprazole, clozapine, cyamemazin, haloperidol, loxapine, olanzapine, risperidone).
Antidepressants (Amitriptyline, Citalopram, Clomipramine, Duloxetine, Escitalopam, Fluoxetine, Mianserine, Mirtazapine, Nortriptyline, Paroxetine, Sertraline, Venlafaxine).
Anxyolitics
Pregnant or breastfeeding women
Persons deprived of their liberty by a judicial or administrative decision
Persons admitted to a health or social institution for purposes other than research
Adults subject to a legal protection measure (guardianship, curatorship)
Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Participation in another research study of the current study
Contraindication for fMRI scanning
Participant not agreeing to be informed in the event of the incidental discovery of an anomaly on MRI
• For visit number 2 :
Alcohol consumption (> 3 drinks) in the 24h before the experiment
Alcohol consumption the day of the experiment
Cafeine consumption 1 hour or less before the experiment
Drug consumption within the 24h preceding the experiment
Antimalarial treatment within the 3 days preceding the experiment
Primary purpose
Allocation
Interventional model
Masking
86 participants in 2 patient groups
Loading...
Central trial contact
Samy Adrian FOUDIL; Emiliano MACALUSO, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal